More good news for TheCW this week. For starters, the return episode of The Vampire Diaries, “Brave New World”, (See our coverage of the premiere and more here) showed zilcho audience attrition over the season one finale episode. The Vampire Diaries brought every last bloodsucker fan back to their televisions last night to catch up on what’s been going down in Mystic Falls, and apparently they liked it because TheCW’s new offering of the evening, the thrice adapted Nikita, sustained The Vampire Diaries viewers and packed a few more on for good measure. Like yesterday’s wins for Hellcats, Nikita also showed some of TheCW’s svelte musculature in the female demos – but I’m sure a ton of guys tuned in to ogle at Maggie Q. Here’s the breakdown from TheCW:
The series premiere of NIKITA matched The CW’s all-time best ratings in the Thursday 9-10:00p.m. time period among women 18-34 (1.9/5), according to preliminary Live Plus Same Day Nielsen ratings for Thursday, Sept. 9, 2010. NIKITA also delivered the largest audience (3.6million) in the time period in over 18 months, since 1/29/09.
NIKITA delivered year-to-year gains, improving on the SUPERNATURAL debut last season by 12% in women 18-34 and 6% in total viewers. NIKITA also built on its VAMPIRE DIARIES premiere lead-in by 9% in total viewers (3.6mil v. 3.3mil).
The second season opener of The CW’s sophomore hit THE VAMPIRE DIARIES scored its best women 18-34 (2.8/9) performance since 2/4/10.
THE VAMPIRE DIARIES was virtually flat with its explosive season finale last May, in all key demographics. VAMPIRE DIARIES retained a large chunk of its massive series premiere last year, keeping about 87% of its year ago adults 18-34 (1.9/6) and 90% of its year ago women 18-34 (2.8/9) delivery.
Despite facing a gigantic season opener for the NFL, The CW scored its highest rated Thursday night with women 18-34 (2.3/7) and women 18-49 (2.0/6) in almost a year, since 11/12/09.
With debuts of THE VAMPIRE DIARIES and NIKITA, The CW ranked second on Thursday night among women 18-34 (2.3/5), adults 18-34 (1.6/5), females 12-34 (2.2/7) and persons 12-34 (1.5/5).